# Tricaprilin In Age-Associated Memory Impairment

> **NCT00355550** · PHASE2 · COMPLETED · sponsor: **Cerecin** · enrollment: 156 (actual)

## Conditions studied

- Age-Associated Memory Impairment

## Interventions

- **DRUG:** Tricaprilin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00355550
- **Lead sponsor:** Cerecin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2020-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00355550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00355550, "Tricaprilin In Age-Associated Memory Impairment". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00355550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*